title: Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 protein.
abstract: Niemann-Pick type C (NPC) disease, a rare autosomal recessive disorder caused mostly by mutation in NPC1 gene, is pathologically characterized by the accumulation of free cholesterol in brain and other tissues. This is accompanied by gliosis and loss of neurons in selected brain regions, including the cerebellum. Recent studies have shown that NPC disease exhibits intriguing parallels with Alzheimer's disease, including the presence of neurofibrillary tangles and increased levels of amyloid precursor protein (APP)-derived β-amyloid (Aβ) peptides in vulnerable brain neurons. To evaluate the role of Aβ in NPC disease, we determined the gene expression profile in selected brain regions of our recently developed bigenic ANPC mice, generated by crossing APP transgenic (Tg) mice with heterozygous Npc1-deficient mice. The ANPC mice exhibited exacerbated neuronal and glial pathology compared to other genotypes [i.e., APP-Tg, double heterozygous (Dhet), Npc1-null and wild-type mice]. Analysis of expression profiles of 86 selected genes using real-time RT-PCR arrays showed a wide-spectrum of alterations in the four genotypes compared to wild-type controls. The changes observed in APP-Tg and Dhet mice are limited to only few genes involved mostly in the regulation of cholesterol metabolism, whereas Npc1-null and ANPC mice showed alterations in the expression profiles of a number of genes regulating cholesterol homeostasis, APP metabolism, vesicular trafficking and cell death mechanism in both hippocampus and cerebellum compared to wild-type mice. Intriguingly, ANPC and Npc1-null mice, with some exceptions, exhibited similar changes, although more genes were differentially expressed in the affected cerebellum than the relatively spared hippocampus. The altered gene profiles were found to match with the corresponding protein levels. These results suggest that lack of Npc1 protein can alter the expression profile of selected transcripts as well as proteins, and APP overexpression influences cerebral pathology by enhancing changes triggered by Npc1 deficiency in the bigenic line.
authors: Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
authors: Mahua
authors: M
authors: Maulik
authors: Gopal
authors: G
authors: Thinakaran
authors: Satyabrata
authors: S
authors: Kar
mesh_terms: D016564:Amyloid beta-Protein Precursor / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics / Q000378:metabolism; D002352:Carrier Proteins; D002401:Cathepsin B / Q000235:genetics / Q000378:metabolism; D002402:Cathepsin D / Q000235:genetics / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D005838:Genotype; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins / Q000172:deficiency*; D051379:Mice; D008822:Mice, Transgenic; D000077296:Niemann-Pick C1 Protein; D052556:Niemann-Pick Disease, Type C / Q000235:genetics* / Q000378:metabolism; D015203:Reproducibility of Results; D033921:Vesicular Transport Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D016564:Amyloid beta-Protein Precursor; D001057:Apolipoproteins E; D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins; C106881:NPC1 protein, human; D000077296:Niemann-Pick C1 Protein; C497045:Npc2 protein, mouse; D033921:Vesicular Transport Proteins; D002784:Cholesterol; D002401:Cathepsin B; D002402:Cathepsin D
references: J Neurosci. 2010 Feb 3;30(5):1648-56
references: 20130175
references: Mol Neurobiol. 2013 Feb;47(1):37-63
references: 22983915
references: Hum Mol Genet. 2012 Aug 15;21(16):3632-46
references: 22619379
references: Ann Neurol. 2002 Sep;52(3):351-5
references: 12205649
references: Neuron. 2011 May 12;70(3):410-26
references: 21555069
references: Neurochem Res. 2007 Apr-May;32(4-5):739-50
references: 17191138
references: Acta Neuropathol. 1995;90(6):547-51
references: 8615074
references: Biochim Biophys Acta. 2004 Oct 11;1685(1-3):28-37
references: 15465424
references: J Biol Chem. 2006 Jun 30;281(26):17890-9
references: 16644737
references: Brain. 2009 Feb;132(Pt 2):402-16
references: 19059977
references: Biochim Biophys Acta. 2009 Jul;1791(7):659-70
references: 19416638
references: Neuron. 2009 Aug 13;63(3):287-303
references: 19679070
references: Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15330-5
references: 21896731
references: J Neurosci. 2002 Mar 1;22(5):1679-89
references: 11880497
references: J Neuropathol Exp Neurol. 2005 Apr;64(4):323-33
references: 15835268
references: Trends Neurosci. 2001 Nov;24(11 Suppl):S45-8
references: 11881745
references: J Neurochem. 2009 Dec;111(6):1275-308
references: 20050287
references: Am J Pathol. 2004 Mar;164(3):975-85
references: 14982851
references: Am J Pathol. 2007 Sep;171(3):962-75
references: 17631520
references: Biochim Biophys Acta. 2010 Aug;1801(8):934-44
references: 20359547
references: Annu Rev Biochem. 2007;76:629-45
references: 17263661
references: J Neuropathol Exp Neurol. 2009 Jan;68(1):1-14
references: 19104448
references: Glia. 2010 Aug 15;58(11):1267-81
references: 20607864
references: Science. 1997 Jul 11;277(5323):232-5
references: 9211850
references: Neurology. 2011 Jan 25;76(4):366-72
references: 21205675
references: Am J Pathol. 2004 Sep;165(3):843-53
references: 15331409
references: Trends Mol Med. 2003 Mar;9(3):94-101
references: 12657430
references: Biochim Biophys Acta. 2004 Oct 11;1685(1-3):63-76
references: 15465427
references: Brain Pathol. 2008 Apr;18(2):240-52
references: 18363935
references: J Biol Chem. 2005 Apr 29;280(17):17020-6
references: 15711015
references: Arterioscler Thromb Vasc Biol. 2004 May;24(5):806-15
references: 14764421
references: J Comp Neurol. 2001 May 7;433(3):415-25
references: 11298365
references: Am J Pathol. 2009 Dec;175(6):2540-56
references: 19893049
references: Handb Clin Neurol. 2008;89:245-60
references: 18631749
references: J Biol Chem. 1987 Dec 15;262(35):17002-8
references: 3680287
references: Curr Drug Targets. 2011 Jul 1;12(8):1188-93
references: 21561417
references: Int J Alzheimers Dis. 2010 Dec 20;2011:548380
references: 21197446
references: Biochem Soc Trans. 2002 Nov;30(Pt 6):1091-5
references: 12440980
references: J Lipid Res. 2004 Aug;45(8):1375-97
references: 15254070
references: Am J Pathol. 2004 Mar;164(3):757-61
references: 14982829
references: Biochem Soc Trans. 2005 Nov;33(Pt 5):1101-5
references: 16246055
references: PLoS One. 2006 Dec 20;1:e19
references: 17183645
references: Mol Genet Metab. 2005 Jan;84(1):9-17
references: 15639190
references: J Biol Chem. 2001 Jun 15;276(24):21562-70
references: 11279122
references: Hum Mol Genet. 2009 Mar 1;18(5):956-65
references: 19074461
references: Hum Mol Genet. 2012 Nov 15;21(22):4857-75
references: 22869680
references: Cell Mol Life Sci. 2003 Jun;60(6):1158-71
references: 12861382
references: Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S120-6
references: 14574625
references: FASEB J. 2008 Oct;22(10):3617-27
references: 18591368
references: Expert Rev Mol Med. 2008 Sep 10;10:e26
references: 18782459
references: Brain Pathol. 1998 Jan;8(1):163-74
references: 9458174